So, Chen et al. (2020) proposed that specific antibodies and small molecules can prevent the binding between ACE2 and the receptors (RBD) of the virus, and this way could represent a potential strategy against COVID-19 disease prevention and control. Here, ACE2 is linked to COVID-19.